News from ESC congress 2019: New ESC/EAS guidelines for dyslipidaemia management published

被引：3
|
作者：
Stock, Jane [1 ]
机构：
[1] World Trade Ctr Goteborg, European Atherosclerosis Soc, Massans Gata 10, SE-41251 Gothenburg, Sweden
来源：
ATHEROSCLEROSIS | 2019年 / 291卷
关键词：
ESC; 2019; Congress; New guidelines; PCSK9 INHIBITOR EVOLOCUMAB; LOW LDL-CHOLESTEROL; RISK; EFFICACY; DISEASE; SAFETY;
D O I：
10.1016/j.atherosclerosis.2019.09.013
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：124 / 126
页数：3
相关论文
共 50 条
  • [31] New Recommendations and Revised Concepts in Recent Guidelines on the Management of Dyslipidemias to Prevent Cardiovascular Disease: the 2018 ACC/AHA and 2019 ESC/EAS Guidelines
    Viraj Raygor
    Amit Khera
    Current Cardiology Reports, 2020, 22
  • [32] The new guidelines of the ESC 2021 ESC/EACTS Guidelines for the management of valvular heart disease [1]
    Zweiker, R.
    JOURNAL FUR KARDIOLOGIE, 2022, 29 (3-4): : 70 - 74
  • [33] New 2023 ESC Guidelines for the management of endocarditis
    Flachskampf, Frank Arnold
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2024, 149 (22) : 1356 - 1360
  • [34] New ESC Guidelines published on stable coronary artery disease
    Taylor, Jennifer
    EUROPEAN HEART JOURNAL, 2013, 34 (38) : 2927 - 2928
  • [35] Management of cardiomyopathies New ESC guidelines 2023
    Pavo, Noemi
    Hengstenberg, Christian
    HERZ, 2024, 49 (01) : 22 - 32
  • [36] 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (vol 290, pg 140, 2019)
    Mach, Francois
    Baigent, Colin
    Catapano, Alberico L.
    Koskinas, Konstantinos C.
    Casula, Manuela
    Badimon, Lina
    Chapman, M. John
    De Backer, Guy G.
    Delgado, Victoria
    Ference, Brian A.
    Graham, Ian M.
    Halliday, Alison
    Landmesser, Ulf
    Mihaylova, Borislava
    Pedersen, Terje R.
    Riccardi, Gabriele
    Richter, Dimitrios J.
    Sabatine, Marc S.
    Taskinen, Marja-Riitta
    Tokgozoglu, Lale
    Wiklund, Olov
    Nibouche, Djamaleddine
    Zelveian, Parounak H.
    Siostrzonek, Peter
    Najafov, Ruslan
    van de Borne, Philippe
    Pojskic, Belma
    Postadzhiyan, Arman
    Kypris, Lambros
    Spinar, Jindrich
    Larsen, Mogens Lytken
    Eldin, Hesham Salah
    Viigimaa, Margus
    Strandberg, Timo E.
    Ferrieres, Jean
    Agladze, Rusudan
    Laufs, Ulrich
    Rallidis, Loukianos
    Bajnok, Laszlo
    Gudjonsson, Thorbjorn
    Maher, Vincent
    Henkin, Yaakov
    Gulizia, Michele Massimo
    Mussagaliyeva, Aisulu
    Bajraktari, Gani
    Kerimkulova, Alina
    Latkovskis, Gustays
    Hamoui, Omar
    Slapikas, Rimvydas
    Visser, Laurent
    ATHEROSCLEROSIS, 2020, 294 : 80 - 82
  • [37] New ESC guidelines 2019 for the treatment of supraventricular tachycardia
    Kuck, K-H
    Phan, H. L.
    Tilz, R. R.
    HERZ, 2019, 44 (08) : 701 - 711
  • [38] New Guidelines from ESH/ESC
    Haller, Hermann
    NEPHROLOGE, 2015, 10 (01): : 4 - 5
  • [39] 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (vol 41, pg 111, 2019)
    Mach, F.
    EUROPEAN HEART JOURNAL, 2020, 41 (44) : 4255 - 4255
  • [40] ESC/EAS Guidelines for the management of dyslipidaemias (vol 32, pg 1769, 2011)
    Catapano, Alberico L.
    Reiner, Zeljko
    De Backer, Guy
    Graham, Ian
    Taskinen, Marja-Riitta
    Wiklund, Olov
    Agewall, Stefan
    Alegria, Eduardo
    Chapman, M. John
    Durrington, Paul
    Erdine, Serap
    Halcox, Julian
    Hobbs, Richard
    Kjekshus, John
    Filardi, Pasquale Perrone
    Riccardi, Gabriele
    Storey, Robert F.
    Wood, David
    ATHEROSCLEROSIS, 2011, 217 (01) : 2 - 2
12345